Clinical utility of the 21-gene Oncotype DX® Recurrence Score® (RS) assay in hormone receptor-positive, HER2-negative breast cancer (BC)
Keyword(s):
2021 ◽
2009 ◽
Vol 72
(1)
◽
pp. S33-S34
2019 ◽
Vol 51
(3)
◽
pp. 1073-1085
◽
2020 ◽
2011 ◽
Vol 29
(15_suppl)
◽
pp. 620-620
Keyword(s):
2016 ◽
Vol 34
(15_suppl)
◽
pp. 6575-6575
2019 ◽
Vol 26
(5)
◽
pp. 1173-1175
◽